References
- Morabia A, Costanza M C. Recent reversal of trends in hormone therapy use in a European population. Menopause 2006; 13: 111–115
- Kaufert P, Boggs P P, Ettinger B, et al. Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey. Menopause 1998; 5: 197–202
- Hully S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605–613
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
- Hagstad J, Janson P O. The epidemiology of climacteric symptoms. Acta Obstet Gynecol Suppl 1986; 134: 59–65
- The Menopause. Obstetrics and Gynaecology in Chinese Medicine, Maciocia Giovanni. Churchill Livingstone, New York 1998; 741–762
- Chen, J, Chen, T. Dang Gui. Chinese Medical Herbology and Pharmacology. California, Art of Medicine Press. 2000; 17: 918–924
- Chen J, Chen T. Huang Qi. Chinese Medical Herbology and Pharmacology. Art of Medicine Press, California 2000; 17: 847–852
- Zhu D P. Dong quai. Am J Chinese Med 1986; 15: 117–125
- K F Leung, Tay, M, Cheng, S SW, Lin, F. Hong Kong Chinese Version World Health Organization Quality of Life Measure Abbreviated Version. 1997, Hong Kong Hospital Authority.
- Yim T K, Wu W K, Pak W F, Mak D H, Liang S M, Ko K M. Myocardial protection against ischaemia-reperfusion injury by a Polygonum multiflorum extract supplemented ‘Dang-Gui decoction for enriching blood’, a compound formulation, ex vivo. Phytother Res 2000; 14: 195–199
- Wang B H, Ouyang J P, Liu Y M, Wei L, Yang J W. Protective effect of Angelica on ECV305 from injury induced hyperlidemic serum in vitro. Acta Physiologica Sinica 2001; 53: 240–243
- Yan X H, Ouyang J P, Tu S Z, Guo S F, Wang Y. Effects of Angelica sinensis on OLDL-induced decrease of NO release from human endothelial cells and increase of ICAM-1 expression on the surface of human endothelial cells. Chinese J Pharmophysiol 2000; 16: 57–59
- Xu S A, Xu B, Zheng Y R. An experimental study on cardioprotective effect of Astragalus membranaceus on ischemic/reperfusion myocardium in isolated rabbit hearts. Chinese Pharmaceutical J 1999; 34: 5–8
- Tan D, Haines C J, Limpaphayom K K, Holinka C F., Ausmanas M K. Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopausal Asian women from 11 countries: The Pan-Asia menopause (PAM) study. Maturitas 2005; 52: 35–51
- Lam P M, Cheung G WY, Shek D TL, Lee D TS, Haines C J, Chung T KH. A randomized, placebo-controlled, crossover study of tibolone (Livial) on menopause symptoms, psychological well-being, and dyadic relationship of postmenopausal Chinese women and their spouses. Menopause 2004; 11: 416–422
- MacLennan A H, Broadbent J L, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviews 2007, Issue 2
- Eagon C L, Elm M S, Teepe A G, Eagon P K. Medical botanicals: estrogenicity in rat uterus and liver. Proc Annu Meet Am Cancer Res 1997; 38: A1967
- Chang H M, But P. Pharmacology and Applications of Chinese Materia Medica. World Scientific, Hong Kong 1986
- Hirata J D, Swiersz L M, Zell B, Small R, Ettinger B. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997; 68: 981–986
- Fugh-Berman A. Herb–drug interactions. Lancet 2000; 355: 134–137